Evaluation of Neurodevelopmental Outcomes in Premature Twins (Multigestations) with Retinopathy of Prematurity Receiving Anti-VEGF: A Comparison Study

Table 2

Comparison of demographic data and systemic risk factors between IVB treated versus nontreated preamature multigestation neonates.

Parameter		Treatment		value
		Yes	No
Birth weight		1316 ± 266	1340 ± 331	0.722
Gestational age		30 ± 1 (27 to 33)	30 ± 1 (27 to 33)	1.000
Gender	Male	19 (39.6%)	33 (60.0%)	0.475
	Female	29 (60.4%)	22 (40.0%)
Treatment	Treated	48 (100.0%)	0 (0.0%)
	Non treated	0 (0.0%)	55 (100.0%)
Oxygen	No	18 (37.5%)	24 (43.6%)	0.256
	Yes	30 (62.5%)	31 (56.4%)
Ventilator	No	36 (75.0%)	39 (70.9%)	0.856
	Yes	12 (25.0%)	16 (29.1%)
Intraventricular hemorrhage	No	47 (97.9%)	53 (96.4%)	0.653
	Yes	1 (2.1%)	2 (3.6%)
Sepsis	No	30 (62.5%)	36 (65.5%)	0.538
	Yes	18 (37.5%)	19 (34.5%)
Phototherapy	No	19 (39.6%)	24 (43.6%)	0.499
	Yes	29 (60.4%)	31 (56.4%)
Transfusion	No	35 (72.9%)	37 (67.3%)	0.341
	Yes	13 (27.1%)	18 (32.7%)
Anemia	No	44 (91.7%)	50 (90.9%)	0.453
	Yes	4 (8.3%)	5 (9.1%)
ARDS	No	25 (52.1%)	34 (61.8%)	0.033
	Yes	23 (47.9%)	21 (38.2%)

ARDS; acute respiratory distress syndrome.